ASPR Invests $8.3 Million to Expand U.S. Production of Essential Hospital Medicines

URLhttps://aspr.hhs.gov/newsroom/Pages/APIIC-Surgical
Sourceaspr.hhs.gov
Date Published03/24/2026

Additional Reshoring Information:

Company/Division name API Innovation Center (APIIC)
Parent companyAPI Innovation Center (APIIC)
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2026
Domestically, the work will be done:In-house
Capital investment ($):8.3
Country(ies) from which reshored:China,India
City reshored to:St. Louis
State(s) reshored to:MO
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredactive pharmaceutical ingredients (APIs)
What non-domestic negative factors made offshoring less attractive?Supply chain interruption
What domestic positive factors made reshoring more attractive?Government Incentives
Government Incentive dollar amount:8,300,000
Find Reshoring Articles